Another modality to prevent or possibly treat obesity and glaucoma is to intervene directly with drugs capable of reducing inflammation or regulating proteins/genes that are key components of the proinflammatory mechanisms underlying the two pathologies, such as TLR4. The gene discussed is TLR4; the disease is obesity disorder.